• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Under Armour (UA) Stock Advances, Cowen: 'Massive Opportunity'
OPINION

Jim Cramer -- Avoid Caterpillar; own PayPal, Under Armour

  • By Bret Kenwell
  • Feb 22, 2016 2:07 PM EST
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

The Nominees for Best Biopharma CEO of 2015 Are...

  • By Adam Feuerstein
  • Dec 15, 2015 8:14 AM EST
A Trump Tariff on North American Auto Trade Could Kill Jobs, Not Increase Them
INVESTING

A Biotech Believer; Does Manufacturing Still Matter?: Jim Cramer's Best Blogs

  • By Jim Cramer
  • Dec 4, 2015 9:00 PM EST
Dow, S&P 500 and Nasdaq End at Record Highs on Trade Deal Progress
OPINION

Cramer: Ignore the Short-Term Noise, Stick With High-Quality Stocks

  • By Bret Kenwell
  • Sep 1, 2015 11:27 AM EDT
Celgene Stock Falls Following Argus Downgrade
INVESTING

CELG, PFE, REGN, RCPT Jim Cramer's Views

  • By Jim Cramer
  • Aug 31, 2015 1:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up

  • By Scott Rutt
  • Aug 27, 2015 8:22 PM EDT
Immunotherapy Stocks Power Higher on Celgene-Juno Deal
INVESTING

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

  • By Scott Gamm
  • Aug 12, 2015 5:42 PM EDT
Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space
VIDEO

Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space

  • By Scott Gamm
  • Aug 12, 2015 5:00 PM EDT
Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal
STOCKS

Biotech Stock Mailbag: Controversial Stocks Revisited

  • By Adam Feuerstein
  • Aug 7, 2015 6:10 AM EDT
Twitter, Coty, Micron Technology: Doug Kass' Views
INVESTING

Bull Charts -- How'd We Do in July?

  • By Timothy Collins
  • Aug 6, 2015 2:15 PM EDT
Galena Craters on Breast Cancer Vaccine Study Failure
STOCKS

Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up

  • By Adam Feuerstein
  • Jul 27, 2015 10:30 AM EDT
Buy Freeport McMoRan to Profit From Thawing U.S.-China Relations
INVESTING

FCX, CLF, BIIB, COF: Jim Cramer's Views

  • By Jim Cramer
  • Jul 27, 2015 1:00 AM EDT
Jim Cramer's Top Takeaways: National Beverage, Gap Stores
OPINION

Jim cramer's top takeaways: celgene, facebook, amazon.com, netflix, google

  • By Scott Rutt
  • Jul 21, 2015 6:00 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

  • By Scott Rutt
  • Jul 20, 2015 8:31 PM EDT
Netflix's Blowout First Quarter: What Wall Street's Saying
INVESTING

NFLX, CELG, M, GS: Jim Cramer's Views

  • By Jim Cramer
  • Jul 20, 2015 1:00 AM EDT
Gold Prices Could Tank Right Along With Stocks Next Week
INVESTING

Risks and Rewards; Oil Optimism; and the Winners Portfolio Managers Are Missing: Jim Cramer's Best Blogs

  • By Jim Cramer
  • Jul 17, 2015 9:00 PM EDT
Celgene Stock Falls Following Argus Downgrade
INVESTING

Cramer Says Buy Celgene, Avoid AK Steel, Take FitBit Profits

  • By Jim Cramer
  • Jul 16, 2015 12:41 PM EDT
Kinross Gold (KGC) Stock Tumbling Despite Rising Gold Prices
MARKETS

Celgene (CELG) Stock Continues to Climb Following Receptos Acquisition

  • By Tony Owusu
  • Jul 16, 2015 11:48 AM EDT
Cramer: AK Steel Is a Casualty of the Euro, Celgene Is Not a Sell
VIDEO

Cramer: AK Steel Is a Casualty of the Euro, Celgene Is Not a Sell

  • By Jim Cramer
  • Jul 16, 2015 11:42 AM EDT
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Take Notice of the Best Investors in the World

  • By Scott Rutt
  • Jul 15, 2015 8:27 PM EDT
Stocks Under Pressure on Global Growth Woes
MARKETS

Stocks End Winning Streak as Greek Protests Turn Violent

  • By Keris Alison Lahiff
  • Jul 15, 2015 4:02 PM EDT
S&P 500 on Track for Record Close as Crude Closes Higher
MARKETS

Stocks Slip Into Red as Global Uncertainty Returns

  • By Keris Alison Lahiff
  • Jul 15, 2015 2:55 PM EDT
Celgene Stock Falls Following Argus Downgrade
OPINION

3 Biotech Stocks to Trade Off the Receptos Buyout

  • By Jonas Elmerraji
  • Jul 15, 2015 1:56 PM EDT
Stocks Edge Higher as Yellen Speaks; Guess? Jumps on CEO Exit
VIDEO

Stocks Edge Higher as Yellen Speaks; Guess? Jumps on CEO Exit

  • By Keris Alison Lahiff
  • Jul 15, 2015 12:11 PM EDT
Stocks Grind Even Higher as Microsoft, Visa Lead Dow
MARKETS

Stocks Edge Higher on Yellen Testimony; Crude Supplies Drop

  • By Keris Alison Lahiff
  • Jul 15, 2015 10:55 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.